How Saudi investors found their way into an East Bay biotech targeting epilepsy

Hevolution’s first Bay Area investment, in a Berkeley company, could help the company target Alzheimer’s, Parkinson’s and other neurodegenerative diseases.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks